Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532
NCT01388829
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Treatment A
DRUG:
Treatment B
Sponsor
Pfizer